NEW YORK, July 25 – GenomicFX, an animal genomics company based in Austin, Tex., will close its doors in August, GenomeWeb learned Wednesday.

Company officials did not respond to calls. Gerard Davis, the CEO of Genetic Solutions, a Brisbane, Australia-based company that GenomicFX acquired in February, referred a reporter to GenomicFX. GenomicFX’s website contained only a link to Genetic Solutions.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.